Meta Pixel

News and Announcements

Proteomics Investigates Biomarkers for Mesothelioma

  • Published September 08, 2016 4:53PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

6th September 2016, ASX Announcement

  • PILL commences the search for protein biomarkers in the blood that could be used to diagnose mesothelioma.
  • World Health Organisation estimates put the cost of treatment, compensation and settlement upwards of AU$667,00 for every sufferer.
  •  Mesothelioma kills 59,000 people annually.

Perth life sciences company Proteomics International Laboratories Limited (PILL, ASX: PIQ) has begun the detailed search for proteins associated with asbestos mesothelioma.

The research aim to develop a simple blood test for the disease, which could lead to early diagnosis for some of the many thousands of currently undiagnosed people who will die from mesothelioma each year.

To view the full announcement, please click on the button below.

Capital Insights
Where’s the beef? Blackstone just answered the AI question.

In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]

Company Updates
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation

For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]

Join over 45,000+ sophisticated investors

Join Now